Skip to main content

Elevation Oncology, Inc. (ELEV)

NASDAQ: ELEV · IEX Real-Time Price · USD
7.89 0.08 (1.02%)
Oct 25, 2021 4:00 PM EDT - Market closed

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Year20202019
Selling, General & Admin
1.80.54
Research & Development
15.485.34
Operating Expenses
17.285.88
Operating Income
-17.28-5.88
Other Expense / Income
-0.010
Pretax Income
-17.27-5.88
Net Income
-17.27-5.88
Net Income Common
-17.27-5.88
Shares Outstanding (Basic)
11
Shares Outstanding (Diluted)
11
Shares Change
6.43%-
EPS (Basic)
-21.80-7.91
EPS (Diluted)
-21.80-7.91
Free Cash Flow Per Share
-15.62-7.33
EBITDA
-17.25-5.88
EBIT
-17.27-5.88
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).